Neuroscience
Request for Proposals: Kissick Family Foundation Frontotemporal Dementia Grant Program (2025-2026)
Request for Proposals: Kissick Family Foundation Frontotemporal Dementia Grant Program (2025-2026)
Milken Institute Philanthropy’s neuroscientists are experts in their field, working alongside donors to navigate the research landscape. Together, with our partners, SPARC experts identify the areas where philanthropy can be the force that brings together diverse perspectives from across disciplines and sectors, unlocks the areas where progress has stalled, and strives for better diagnostics and treatments for conditions that affect the brain.
Philanthropic Investment for Brain Health
Our brains hold the essence of who we are: our memories, personalities, feelings, as well as the keys to the way our bodies work. There are more than 600 diseases that affect the brain—and every one of them can change how our bodies function and/or how we understand ourselves. Each of these diseases is unique and complex, and together, they impact the lives of one in every six people around the world. Illnesses of the brain range from mental health conditions such as depression and bipolar disorder to neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases, and lesser-known conditions such as misophonia.
Due to the complexity of this vital human organ, brain conditions can be notoriously difficult to diagnose and treat. To better understand these complexities and address gaps in science’s understanding of the brain, ensuring brain research is adequately and strategically funded is of utmost importance.
Current Funding Programs
Accelerating Discovery for Frontotemporal Dementia
Amyotrophic Lateral Sclerosis (ALS)
Neuroscience
Related Content
-
A Global Imperative to Improve Brain Health
Age-related neurological and psychiatric diseases—including dementia, stroke, and late-life depression (LLD)—remain a major and growing public health challenge, as the global population over age 60 is expected to double by 2050.Read Report
KP
SP
TP
Agnes Stephens, Ishita Das, PhD, Sylvie Raver, PhD, Katherine Eyring, PhD, Samantha Kost, PhD, and Tanisha London, PhD -
Frontotemporal Dementia Giving Smarter Guide
Frontotemporal dementia (FTD) refers to a family of neurodegenerative conditions that cause changes in behavior, mood, executive function, language, memory, and motor function. FTD is widely believed to be underdiagnosed and undercounted...Read Report
MM
-
Amyotrophic Lateral Sclerosis (ALS) A Giving Smarter Guide
ALS, commonly known as Lou Gehrig’s disease or motor neurone disease (MND), is a cruel disease that has challenged patients, their families, and the medical community for generations. Although ALS is considered rare, its impact on...Read Report
MH
-
Neurotechnology: A Giving Smarter Guide
When most people think about advances in medicine, drug development is the first thing that comes to mind. However, technology and devices are proving to be valuable options for treating intractable illnesses. Technological solutions in the...Read Report
EH
-
Targeting Tau — Our Hope to Solving the Dementia Crisis
In our systems-based review of the biomedical landscape supporting research of a cellular protein called tau—a common culprit in a number of neurodegenerative diseases—we make the case that focused strategic investment in tau research and...Read Report -
Neurofibromatosis Preclinical Initiatives (NFPI)
The NF Preclinical Initiative (NFPI) represents one of the Children’s Tumor Foundation’s groundbreaking models of scientific collaboration. The NFPI is aimed at accelerating proof of concept testing of potential effective repurposed drugs...Read Report -
Alzheimer's Disease - A Giving Smarter Guide
Alzheimer’s disease is increasingly in the spotlight after a number of high-profile clinical trial failures—an alarming trend as an estimated 5.5 million adult Americans live with this disease, which disproportionally affects the aged...Read Report -
Neurofibromatosis Type 1 - A Giving Smarter Guide
With no effective therapies and no cure, Neurofibromatosis Type 1 (NF1) is a genetic disease that can cause a broad range of abnormalities all throughout the body. A hallmark feature of the disease is the growth of tumors on nerves...Read ReportYK LB EL ER
-
Parkinson's Disease - A Giving Smarter Guide
More than 1 million American lives are affected by Parkinson’s Disease (PD), a chronic, neurodegenerative movement disorder. Mainly affecting the elderly, the cause of PD is unknown. There are currently no treatments that can slow or stop...Read ReportER
L
YK
EL
Our Team
Cara Altimus, PhD
Quinton Banks, PhD
Emily Baxi, PhD
Veronica Beck, PhD
Daniel Pham, PhD
Sylvie Raver, PhD